Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bionor Pharma ASA
DescriptionCombination of Vacc-4x (peptide targeting HIV Gag p24 ) and Vacc-C5 ( Humoral peptide based on modified synthetic peptides from the C5 area of gp 120)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today